Turning Point Therapeutics, Inc. Financing Cash Flow
Turning Point Therapeutics, Inc. reported Financing Cash Flow of $9.37 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-08-08
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $8.97M, a 3.93% decline year-over-year.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $396.00K, a 95.91% decline year-over-year.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $2.60M, a 99.42% decline year-over-year.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $2.38M, a 503.81% increase year-over-year.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $24.00M, a 96.99% decline from fiscal 2020.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $798.74M, a 118.24% increase from fiscal 2019.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $366.00M, a 358.46% increase from fiscal 2018.
- Turning Point Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $79.83M, a 77.99% increase from fiscal 2017.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-06-30 | $8.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $9.37M 10-Q · filed 2022-08-08 | $11.97M derived: sum of 3 quarters · filed 2022-08-08 | $14.35M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | $396.00K 10-Q · filed 2022-05-10 | $3.00M derived: sum of 2 quarters · filed 2022-05-10 | $5.38M derived: sum of 3 quarters · filed 2022-05-10 | $14.72M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.98M derived: sum of 2 quarters · filed 2022-02-28 | $14.32M derived: sum of 3 quarters · filed 2022-08-08 | $24.00M 10-K · filed 2022-02-28 |
| 2021-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $11.72M derived: sum of 2 quarters · filed 2022-08-08 | $21.40M 10-Q · filed 2021-11-09 | $467.57M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | $9.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $19.02M 10-Q · filed 2022-08-08 | $465.19M derived: sum of 3 quarters · filed 2022-08-08 | $465.59M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $9.68M 10-Q · filed 2022-05-10 | $455.85M derived: sum of 2 quarters · filed 2022-05-10 | $456.25M derived: sum of 3 quarters · filed 2022-05-10 | $808.39M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $446.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $446.57M derived: sum of 2 quarters · filed 2022-02-28 | $798.71M derived: sum of 3 quarters · filed 2022-02-28 | $798.74M 10-K · filed 2022-02-28 |
| 2020-09-30 | $394.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $352.54M derived: sum of 2 quarters · filed 2021-11-09 | $352.56M 10-Q · filed 2021-11-09 | $352.51M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $352.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $352.17M 10-Q · filed 2021-08-09 | $352.12M derived: sum of 3 quarters · filed 2022-02-28 | $542.40M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $25.00K 10-Q · filed 2021-05-05 | -$26.00K derived: sum of 2 quarters · filed 2022-02-28 | $190.26M derived: sum of 3 quarters · filed 2022-02-28 | $366.82M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $190.23M derived: sum of 2 quarters · filed 2022-02-28 | $366.79M derived: sum of 3 quarters · filed 2022-02-28 | $366.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | $190.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $366.84M derived: sum of 2 quarters · filed 2020-11-12 | $366.05M 10-Q · filed 2020-11-12 | $445.81M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $176.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $175.76M 10-Q · filed 2020-08-10 | $255.52M derived: sum of 3 quarters · filed 2021-03-01 | $255.55M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$797.00K 10-Q · filed 2020-05-12 | $78.96M derived: sum of 2 quarters · filed 2021-03-01 | $78.99M derived: sum of 3 quarters · filed 2021-03-01 | $79.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $79.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $79.79M derived: sum of 2 quarters · filed 2021-03-01 | $79.83M derived: sum of 3 quarters · filed 2021-03-01 | $79.83M 10-K · filed 2021-03-01 |
| 2018-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $65.00K derived: sum of 2 quarters · filed 2019-11-04 | $71.00K 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $45.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $6.00K 10-Q · filed 2019-05-31 | |||
| 2017-12-31 | $44.85M 10-K · filed 2020-03-18 |